Jason Grebely (J Grebely)

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 54

Top Topics

Alcohol Consumption

Systematic Review

Hepatitis C Virus

Top Venues

Journal of viral hepatitis

Addiction (Abingdon, England)

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

This page only lists publications with an associated author ORCID identifier.

Publications

Jason Grebely
Point-of-care testing for hepatitis C infection: A critical building block for the foundation to achieve elimination. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)
Abdullah Farooq, Heather Valerio, Alice Wheeler, Marianne Martinello, Charles Henderson, David Silk, Louisa Degenhardt, Phillip Read, Gregory J Dore, Jason Grebely, Evan B Cunningham, null null
Needle and syringe sharing among people who have recently injected drugs in Australia: The ETHOS Engage Study. Drug and alcohol review (2024)
Jason Grebely, Susan Matthews, Louise M Causer, Jordan J Feld, Philip Cunningham, Gregory J Dore, Tanya L Applegate
We have reached single-visit testing, diagnosis, and treatment for hepatitis C infection, now what? Expert review of molecular diagnostics 24 (3) (2024)
Hannah Ryan, Gregory J Dore, Jason Grebely, Marianne Byrne, Evan B Cunningham, Marianne Martinello, Andrew R Lloyd, Behzad Hajarizadeh
Hepatitis C treatment outcome among people in prison: The SToP-C study. Liver international : official journal of the International Association for the Study of the Liver (2024)
Abdullah Farooq, Heather Valerio, Alice Wheeler, Marianne Martinello, Charles Henderson, David Silk, Louisa Degenhardt, Phillip Read, Gregory J Dore, Jason Grebely, Evan B Cunningham, null null
Needle and syringe sharing among people who have recently injected drugs in Australia: The ETHOS Engage Study. Drug and alcohol review 43 (4) (2024)
Jason Grebely, Susan Matthews, Louise M Causer, Jordan J Feld, Philip Cunningham, Gregory J Dore, Tanya L Applegate
We have reached single-visit testing, diagnosis, and treatment for hepatitis C infection, now what? Expert review of molecular diagnostics 24 (3) (2024)
Jason Grebely, Susan Matthews, Louise M Causer, Jordan J Feld, Philip Cunningham, Gregory J Dore, Tanya L Applegate
We have reached single-visit testing, diagnosis, and treatment for hepatitis C infection, now what? Expert review of molecular diagnostics (2024)
Abdullah Farooq, Heather Valerio, Alice Wheeler, Marianne Martinello, Charles Henderson, David Silk, Louisa Degenhardt, Phillip Read, Gregory J Dore, Jason Grebely, Evan B Cunningham, null null
Needle and syringe sharing among people who have recently injected drugs in Australia: The ETHOS Engage Study. Drug and alcohol review 43 (4) (2024)
Mohammad Tahir Yousafzai, Maryam Alavi, Heather Valerio, Behzad Hajarizadeh, Jason Grebely, Gregory J Dore
Hepatitis C care cascade before and during the direct-acting antiviral eras in New South Wales, Australia: A population-based linkage study. Journal of viral hepatitis 30 (3) (2023)
Sophy Ting-Fang Shih, Jack Stone, Natasha K Martin, Behzad Hajarizadeh, Evan B Cunningham, Jisoo A Kwon, Colette McGrath, Luke Grant, Jason Grebely, Gregory J Dore, Andrew R Lloyd, Peter Vickerman, Georgina M Chambers
Scale-up of Direct-Acting Antiviral Treatment in Prisons Is Both Cost-effective and Key to Hepatitis C Virus Elimination. Open forum infectious diseases 11 (2) (2023)
Phyo Pyae Nyein, Shane Tillakeratne, Sabai Phyu, Myint Myint Yee, Mya Mya Lwin, Kyaw Linn Htike, May Thu Aung, Jason Grebely, Tanya Applegate, Josh Hanson, Gail Matthews, Kyaw Swar Lin
Evaluation of Simplified HCV Diagnostics in HIV/HCV Co-Infected Patients in Myanmar. Viruses 15 (2) (2023)
Anna S Conway, Annabelle Stevens, Carolyn Murray, Bianca Prain, Cherie Power, Anna McNulty, Nigel Carrington, Heng Lu, Melanie Kingsland, Colette McGrath, Phillip Read, Mitchell Starr, Beth Catlett, Philip Cunningham, Jason Grebely
Hepatitis C Treatment Uptake Following Dried Blood Spot Testing for Hepatitis C RNA in New South Wales, Australia: The NSW DBS Pilot Study. Open forum infectious diseases 10 (11) (2023)
Chrianna Bharat, Paige Webb, Zachary Wilkinson, Rebecca Mcketin, Jason Grebely, Michael Farrell, Adam Holland, Matthew Hickman, Lucy Thi Tran, Brodie Clark, Amy Peacock, Shane Darke, Jih-Heng Li, Louisa Degenhardt
Agreement between self-reported illicit drug use and biological samples: A systematic review and meta-analysis. Addiction (Abingdon, England) (2023)
Lise Lafferty, Yumi Sheehan, Amanda Cochrane, Jason Grebely, Andrew R Lloyd, Carla Treloar
Reducing barriers to the hepatitis C care cascade in prison via point-of-care RNA testing: a qualitative exploration of men in prison using an integrated framework. Addiction (Abingdon, England) (2023)
Mohammad Tahir Yousafzai, Maryam Alavi, Heather Valerio, Behzad Hajarizadeh, Jason Grebely, Gregory J Dore
Hepatitis C care cascade before and during the direct-acting antiviral eras in New South Wales, Australia: A population-based linkage study. Journal of viral hepatitis 30 (3) (2023)
Lise Lafferty, Y Sheehan, A Cochrane, Jason Grebely, A R Lloyd, Carla Treloar
Reducing barriers to the hepatitis C care cascade in prison via point-of-care RNA testing: A qualitative exploration of men in prison using an integrated framework. Addiction (Abingdon, England) (2023)
Mohammad Tahir Yousafzai, Maryam Alavi, Heather Valerio, Behzad Hajarizadeh, Jason Grebely, Gregory J Dore
Hepatitis C care cascade before and during the direct-acting antiviral eras in New South Wales, Australia: A population-based linkage study. Journal of viral hepatitis 30 (3) (2023)
Sophy Ting-Fang Shih, Jack Stone, Natasha K Martin, Behzad Hajarizadeh, Evan B Cunningham, Jisoo A Kwon, Colette McGrath, Luke Grant, Jason Grebely, Gregory J Dore, Andrew R Lloyd, Peter Vickerman, Georgina M Chambers
Scale-up of Direct-Acting Antiviral Treatment in Prisons Is Both Cost-effective and Key to Hepatitis C Virus Elimination. Open forum infectious diseases 11 (2) (2023)
Phyo Pyae Nyein, Shane Tillakeratne, Sabai Phyu, Myint Myint Yee, Mya Mya Lwin, Kyaw Linn Htike, May Thu Aung, Jason Grebely, Tanya Applegate, Josh Hanson, Gail Matthews, Kyaw Swar Lin
Evaluation of Simplified HCV Diagnostics in HIV/HCV Co-Infected Patients in Myanmar. Viruses 15 (2) (2023)
Behzad Hajarizadeh, Joanne M Carson, Marianne Byrne, Jason Grebely, Evan B Cunningham, Janaki Amin, Peter Vickerman, Natasha K Martin, Carla Treloar, Marianne Martinello, Andrew R Lloyd, Gregory J Dore, null null
Incidence of hepatitis C virus infection in the prison setting: The SToP-C study. Journal of viral hepatitis (2023)
Mohammad Tahir Yousafzai, Maryam Alavi, Heather Valerio, Behzad Hajarizadeh, Jason Grebely, Gregory J Dore
Hepatitis C care cascade before and during the direct acting antiviral eras in New South Wales, Australia: a population-based linkage study. Journal of viral hepatitis (2022)
Beth Catlett, Behzad Hajarizadeh, Evan Cunningham, Brett Wolfson-Stofko, Alice Wheeler, Benazir Khandaker-Hussain, Jordan J Feld, Elisa Martró, Stéphane Chevaliez, Jean Michel Pawlotsky, Chrianna Bharat, Philip H Cunningham, Gregory J Dore, Tanya Applegate, Jason Grebely
Diagnostic Accuracy of Assays Using Point-of-Care Testing or Dried Blood Spot Samples for the Determination of Hepatitis C Virus RNA: A Systematic Review. The Journal of infectious diseases 226 (6) (2022)
Mohammad Tahir Yousafzai, Maryam Alavi, Heather Valerio, Behzad Hajarizadeh, Jason Grebely, Gregory J Dore
Hepatitis C care cascade before and during the direct-acting antiviral eras in New South Wales, Australia: A population-based linkage study. Journal of viral hepatitis (2022)
Anna S Conway, Heather Valerio, Maryam Alavi, David Silk, Carla Treloar, Behzad Hajarizadeh, Alison D Marshall, Marianne Martinello, Andrew Milat, Adrian Dunlop, Carolyn Murray, Bianca Prain, Charles Henderson, Janaki Amin, Phillip Read, Pip Marks, Louisa Degenhardt, Jeremy Hayllar, David Reid, Carla Gorton, Thao Lam, Michael Christmass, Alexandra Wade, Mark E Montebello, Gregory J Dore, Jason Grebely, null null
A Testing Campaign Intervention Consisting of Peer-Facilitated Engagement, Point-of-Care HCV RNA Testing, and Linkage to Nursing Support to Enhance Hepatitis C Treatment Uptake among People Who Inject Drugs: The ETHOS Engage Study. Viruses 14 (7) (2022)
Jason Grebely, Gregory J Dore, Frederick L Altice, Brian Conway, Alain H Litwin, Brianna L Norton, Olav Dalgard, Edward J Gane, Oren Shibolet, Ronald G Nahass, Anne F Luetkemeyer, Cheng-Yuan Peng, David Iser, Isaias Noel Gendrano, Michelle M Kelly, Peggy Hwang, Ernest Asante-Appiah, Barbara A Haber, Eliav Barr, Michael N Robertson, Heather Platt
Reinfection and Risk Behaviors After Treatment of Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy : A Cohort Study. Annals of internal medicine 175 (9) (2022)
Mohammad Tahir Yousafzai, Maryam Alavi, Heather Valerio, Behzad Hajarizadeh, Jason Grebely, Gregory J Dore
Hepatitis C care cascade before and during the direct-acting antiviral eras in New South Wales, Australia: A population-based linkage study. Journal of viral hepatitis (2022)
Joanne M Carson, Gregory J Dore, Andrew R Lloyd, Jason Grebely, Marianne Byrne, Evan Cunningham, Janaki Amin, Peter Vickerman, Natasha K Martin, Carla Treloar, Marianne Martinello, Gail V Matthews, Behzad Hajarizadeh, null null
Hepatitis C Virus Reinfection Following Direct-Acting Antiviral Treatment in the Prison Setting: The SToP-C Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 75 (10) (2022)
Anna S Conway, Phillip Read, Rosie Gilliver, Tony McNaughton, Heather Valerio, Evan B Cunningham, Charles Henderson, Brett Hadlow, Katrina Molloy, Anna Doab, Shane Tillakeratne, Lucy Pepolim, Mary Ellen Harrod, Gregory J Dore, Jason Grebely
Awareness of HCV Status and Preferences for Testing and Treatment among People with Recent Injecting Drug Use at a Peer-Led Needle and Syringe Program: The TEMPO Pilot Study. Viruses 14 (11) (2022)
Mohammad Tahir Yousafzai, Maryam Alavi, Heather Valerio, Behzad Hajarizadeh, Jason Grebely, Gregory J Dore
Hepatitis C care cascade before and during the direct-acting antiviral eras in New South Wales, Australia: A population-based linkage study. Journal of viral hepatitis (2022)
Mohammad Tahir Yousafzai, Maryam Alavi, Heather Valerio, Behzad Hajarizadeh, Jason Grebely, Gregory J Dore
Timely Hepatitis C RNA Testing and Treatment in the Era of Direct-Acting Antiviral Therapy among People with Hepatitis C in New South Wales, Australia. Viruses 14 (7) (2022)
Jisoo A Kwon, Gregory J Dore, Behzad Hajarizadeh, Maryam Alavi, Heather Valerio, Jason Grebely, Rebecca Guy, Richard T Gray
Australia could miss the WHO hepatitis C virus elimination targets due to declining treatment uptake and ongoing burden of advanced liver disease complications. PloS one 16 (9) (2021)
Jason Grebely, Lucy Tran, Louisa Degenhardt, Alexander Dowell-Day, Thomas Santo, Sarah Larney, Matthew Hickman, Peter Vickerman, Clare French, Kerryn Butler, Daisy Gibbs, Heather Valerio, Phillip Read, Gregory J Dore, Behzad Hajarizadeh
Association Between Opioid Agonist Therapy and Testing, Treatment Uptake, and Treatment Outcomes for Hepatitis C Infection Among People Who Inject Drugs: A Systematic Review and Meta-analysis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 73 (1) (2021)
Claire F Ferraro, Daniel E Stewart, Jason Grebely, Lucy T Tran, Shally Zhou, Carla Puca, Behzad Hajarizadeh, Sarah Larney, Thomas Santo, Julian P T Higgins, Peter Vickerman, Louisa Degenhardt, Matthew Hickman, Clare E French
Association between opioid agonist therapy use and HIV testing uptake among people who have recently injected drugs: a systematic review and meta-analysis. Addiction (Abingdon, England) 116 (7) (2021)
Heather Valerio, Maryam Alavi, David Silk, Carla Treloar, Marianne Martinello, Andrew Milat, Adrian Dunlop, Jo Holden, Charles Henderson, Janaki Amin, Phillip Read, Philippa Marks, Louisa Degenhardt, Jeremy Hayllar, David Reid, Carla Gorton, Thao Lam, Gregory J Dore, Jason Grebely
Progress Towards Elimination of Hepatitis C Infection Among People Who Inject Drugs in Australia: The ETHOS Engage Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 73 (1) (2021)
Mohammad Tahir Yousafzai, Sahar Bajis, Maryam Alavi, Jason Grebely, Gregory J Dore, Behzad Hajarizadeh
Global cascade of care for chronic hepatitis C virus infection: A systematic review and meta-analysis. Journal of viral hepatitis 28 (10) (2021)
Suzanne Nielsen, Paul Sanfilippo, Vendula Belackova, Carolyn A Day, Edmund Silins, Nicholas Lintzeris, Raimondo Bruno, Jason Grebely, Kari Lancaster, Robert Ali, James Bell, Paul Dietze, Louisa Degenhardt, Michael Farrell, Briony Larance
Perceptions of injectable opioid agonist treatment (iOAT) among people who regularly use opioids in Australia: findings from a cross-sectional study in three Australian cities. Addiction (Abingdon, England) 116 (6) (2020)
Jason Grebely, Phillip Read, Evan B Cunningham, Martin Weltman, Gail V Matthews, Adrian Dunlop, Mark Montebello, Marianne Martinello, Rosie Gilliver, Philippa Marks, Tanya L Applegate, Gregory J Dore, null null
Elbasvir and grazoprevir for hepatitis C virus genotype 1 infection in people with recent injecting drug use (DARLO-C): An open-label, single-arm, phase 4, multicentre trial. Health science reports 3 (2) (2020)
Briony Larance, Louisa Degenhardt, Jason Grebely, Suzanne Nielsen, Raimondo Bruno, Paul M Dietze, Kari Lancaster, Sarah Larney, Thomas Santo, Marian Shanahan, Sonja Memedovic, Robert L Ali, Michael Farrell
Perceptions of extended-release buprenorphine injections for opioid use disorder among people who regularly use opioids in Australia. Addiction (Abingdon, England) 115 (7) (2020)
Sahar Bajis, Jason Grebely, Lucy Cooper, Julie Smith, Greg Owen, Alan Chudleigh, Behzad Hajarizadeh, Marianne Martinello, Sara Adey, Phillip Read, Rosemary Gilliver, Tanya Applegate, Carla Treloar, Lisa Maher, Gregory J Dore
Hepatitis C virus testing, liver disease assessment and direct-acting antiviral treatment uptake and outcomes in a service for people who are homeless in Sydney, Australia: The LiveRLife homelessness study. Journal of viral hepatitis 26 (8) (2019)
Marianne Martinello, Behzad Hajarizadeh, Jason Grebely, Gregory J Dore, Gail V Matthews
Management of acute HCV infection in the era of direct-acting antiviral therapy. Nature reviews. Gastroenterology & hepatology 15 (7) (2019)
Adam Trickey, Hannah Fraser, Aaron G Lim, Josephine G Walker, Amy Peacock, Samantha Colledge, Janni Leung, Jason Grebely, Sarah Larney, Natasha K Martin, Louisa Degenhardt, Matthew Hickman, Margaret T May, Peter Vickerman
Modelling the potential prevention benefits of a treat-all hepatitis C treatment strategy at global, regional and country levels: A modelling study. Journal of viral hepatitis 26 (12) (2019)
Sahar Bajis, Jason Grebely, Behzad Hajarizadeh, Tanya Applegate, Alison D Marshall, Mary Ellen Harrod, Jude Byrne, Nicky Bath, Phillip Read, Michael Edwards, Carla Gorton, Jeremy Hayllar, Victoria Cock, Steven Peterson, Claire Thomson, Martin Weltman, Meryem Jefferies, William Wood, Paul Haber, Nadine Ezard, Marianne Martinello, Lisa Maher, Gregory J Dore, null null
Hepatitis C virus testing, liver disease assessment and treatment uptake among people who inject drugs pre- and post-universal access to direct-acting antiviral treatment in Australia: The LiveRLife study. Journal of viral hepatitis 27 (3) (2019)
Beth Catlett, Francois M J Lamoury, Sahar Bajis, Behzad Hajarizadeh, Danica Martinez, Yasmin Mowat, Philip H Cunningham, Brendan P Jacka, Gavin A Cloherty, Philippa Marks, Gregory J Dore, Jason Grebely, Tanya L Applegate
Evaluation of a hepatitis C virus core antigen assay from venepuncture and dried blood spot collected samples: A cohort study. Journal of viral hepatitis 26 (12) (2019)
Alain H Litwin, Martine Drolet, Chizoba Nwankwo, Martha Torrens, Andrej Kastelic, Stephan Walcher, Lorenzo Somaini, Emily Mulvihill, Jochen Ertl, Jason Grebely
Perceived barriers related to testing, management and treatment of HCV infection among physicians prescribing opioid agonist therapy: The C-SCOPE Study. Journal of viral hepatitis 26 (9) (2019)
Matthew Hickman, Jason Grebely, Julie Bruneau, Phillip Coffin, Louisa Degenhardt, Sharon Hutchinson, Sarah Larney, Natasha Martin, Carla Treloar, Peter Vickerman
New developments and opportunities for preventing hepatitis C virus (HCV) among people who use and inject drugs-announcing an Addiction series. Addiction (Abingdon, England) 112 (7) (2019)
Emmanuel Fortier, Andreea Adelina Artenie, Geng Zang, Didier Jutras-Aswad, Élise Roy, Jason Grebely, Julie Bruneau
Short and sporadic injecting cessation episodes as predictors of incident hepatitis C virus infection: findings from a cohort study of people who inject drugs in Montréal, Canada. Addiction (Abingdon, England) 114 (8) (2019)
Chaturaka Rodrigo, Preston Leung, Andrew R Lloyd, Rowena A Bull, Fabio Luciani, Jason Grebely, Gregory J Dore, Tanya Applegate, Kimberly Page, Julie Bruneau, Andrea L Cox, William Osburn, Arthur Y Kim, Naglaa H Shoukry, Georg M Lauer, Lisa Maher, Janke Schinkel, Maria Prins, Margaret E Hellard, Auda A Eltahla, null null
Genomic variability of within-host hepatitis C variants in acute infection. Journal of viral hepatitis 26 (4) (2019)
Amy Peacock, Janni K Y Leung, Sarah Larney, Samantha Colledge, Matthew Hickman, Jürgen Rehm, Gary A Giovino, Robert West, Wayne Denis Hall, Paul Griffiths, Robert L Ali, Linda R Gowing, John Marsden, Alize J Ferrari, Jason Grebely, Michael Farrell, Louisa Degenhardt
Global statistics on alcohol, tobacco and illicit drug use: 2017 status report. Addiction (Abingdon, England) 113 (10) (2018)
Maryam Alavi, Naveed Zafar Janjua, M Chong, Jason Grebely, Esther J Aspinall, H Innes, Heather Valerio, Behzad Hajarizadeh, P C Hayes, Mel Krajden, Janaki Amin, Matthew G Law, Jacob George, D J Goldberg, S J Hutchinson, Gregory J Dore
Trends in hepatocellular carcinoma incidence and survival among people with hepatitis C: An international study. Journal of viral hepatitis 25 (5) (2018)
Jason Grebely, Sarah Larney, Amy Peacock, Samantha Colledge-Frisby, Janni K Y Leung, Matthew Hickman, Peter Vickerman, Sarah Blach, Evan B Cunningham, Konstantin Dumchev, Michael T Nurmohamed, Jack Stone, Adam Trickey, Homie Razavi, Richard P Mattick, Michael Farrell, Gregory J Dore, Louisa Degenhardt
Global, regional, and country-level estimates of hepatitis C infection among people who have recently injected drugs. Addiction (Abingdon, England) 114 (1) (2018)
Matthew Hickman, Sarah Larney, Amy Peacock, Hayley E Jones, Jason Grebely, Louisa Degenhardt
Competing global statistics on prevalence of injecting drug use: why does it matter and what can be done? Addiction (Abingdon, England) 113 (10) (2018)
Jisoo A Kwon, Gregory J Dore, Jason Grebely, Behzad Hajarizadeh, Rebecca J Guy, Evan B Cunningham, Cherie Power, Chris Estes, Homie Razavi, Richard T Gray, null null
Australia on track to achieve WHO HCV elimination targets following rapid initial DAA treatment uptake: A modelling study. Journal of viral hepatitis 26 (1) (2018)
Emma Day, Margaret E Hellard, Carla Treloar, Julie Bruneau, Natasha K Martin, Anne Øvrehus, Olav Dalgard, Andrew Lloyd, John F Dillon, Matthew Hickman, Jude Byrne, Alain Litwin, Mojca Maticic, Philip Bruggmann, Havard Midgard, Brianna Norton, Stacey Trooskin, Jeffrey Victor Lazarus, Jason Grebely, null null
Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework. Liver international : official journal of the International Association for the Study of the Liver 39 (1) (2018)
Brendan P Jacka, B C Bray, T L Applegate, B D L Marshall, V D Lima, K Hayashi, K DeBeck, J Raghwani, P R Harrigan, M Krajden, J S G Montaner, Jason Grebely
Drug use and phylogenetic clustering of hepatitis C virus infection among people who use drugs in Vancouver, Canada: A latent class analysis approach. Journal of viral hepatitis 25 (1) (2017)
Jason Grebely, Maryam Alavi, Michelle Micallef, Adrian J Dunlop, Anne C Balcomb, Nghi Phung, Martin D Weltman, Carolyn A Day, Carla Treloar, Nicky Bath, Paul S Haber, Gregory J Dore, null null
Treatment for hepatitis C virus infection among people who inject drugs attending opioid substitution treatment and community health clinics: the ETHOS Study. Addiction (Abingdon, England) 111 (2) (2015)